Company Overview of Shire Canada Inc.
Shire Canada Inc. provides therapies for attention deficit hyperactivity disorder (ADHD), human genetics, and gastrointestinal and renal diseases. It offers products for the treatment of ulcerative colitis, kidney diseases, Fabry diseases, and Hunter syndrome. Shire Canada Inc. was formerly known as Shire BioChem Inc. and changed its name to Shire Canada Inc. in September 2007. The company was incorporated in 1972 and is based in Saint-Laurent, Canada. As of May 11, 2001, Shire Canada Inc. operates as a subsidiary of Shire plc.
2250 Alfred-Nobel Boulevard
Saint-Laurent, QC H4S 2C9
Founded in 1972
Key Executives for Shire Canada Inc.
Similar Private Companies By Industry
|Topigen Pharmaceuticals, Inc.||Americas|
|GLyPharma Therapeutic Inc.||Americas|
|Sepracor Canada Limited||Americas|
|Insymbiosis Discovery Inc.||Americas|
|Triage Therapeutics Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Shire Canada Inc., please visit www.shirecanada.com. Company data is provided by Capital IQ. Please use this form to report any data issues.